<p>Disclosed are dihydroindolone compounds which can modulate the activity of protein tyrosine kinases, a method for preparing the same, and pharmaceutical compositions comprising the same. Also disclosed are use of such compounds and pharmaceutical compositions thereof in the treatment and/or prophylaxis of protein tyrosine kinase associated diseases in an organism, particularly in the treatment and/or prophylaxis of tumors and fibroblast proliferation associated diseases.</p>
申请公布号
EP2292613(B1)
申请公布日期
2015.09.30
申请号
EP20090749471
申请日期
2009.05.25
申请人
SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY;CHIA TAI TIANQING PHARMACEUTICAL GROUP CO.,LTD